Corporate Information

Dr Thomas Szuran
Chief Products & Home Care; Deputy CEO

• Member of the Executive Committee of the Galenica Group since 2019, born in 1967, Swiss citizen;
• since January 2025 Deputy CEO of the Galenica Group
• Career highlights: After having graduated from ETH Zurich, Thomas Szuran acted in various roles at Abbott Laboratories between 1997 and 2002, including being Sales & Marketing Manager for the Eastern European & Mediterranean region. He later became Sales Director at Pfizer Switzerland (Zurich) (2002 – 2005) and Country Manager at Pfizer in Israel (2005 to 2007). He joined Biomed AG in Dübendorf in 2008 as Marketing Director and was CEO of Biomed AG from 2011 to 2018. In 2019, Thomas Szuran became Head Products & Brands Business sector at the Galenica Group.
• Qualification: Dr sc. nat. Federal Institute of Technology (ETH) Zurich
• Other main activities: Mandates by order of Galenica: Member of the Board of MediService AG, Emeda AG and Puravita AG. In addition, member of the Board of Trustees of the Galenica Pension Fund.

Lukas Ackermann
Chief IT & Digital Business

• Member of the Executive Committee of the Galenica Group since 2022, born in 1972, Swiss citizen
• Career highlights: Lukas Ackermann started off his career as Product Manager at Helsana Insurance Company Ltd and then became Deputy Head of Product Management (1999 – 2002). In 2002, he was appointed CEO of Medicall Ltd. Afterwards, he became Head of Health Care Market at Synesix Ltd (2008 – 2010). The two following years, Lukas Ackermann was Head of I-Lab at the University of St.Gallen, and from 2013 to 2020 he was General Manager / CEO of amétiq Ltd. Before Lukas Ackermann became Head of IT & Digital Services at Galenica Ltd at the Galenica Group in 2021, he was Managing Director of HCI Solutions Ltd.
• Qualification: Diploma in Natural Sciences from Federal Institute of Technology (ETH) Zurich and MAS MTEC from the Federal Institute of Technology (ETH) Zurich.
• Other main activities: -

Julian Fiessinger
CFO Galenica Group

• Member of the Executive Committee of the Galenica Group since 1st January 2025, born in 1982, Swiss and German citizen
• Career highlights: Julian Fiessinger started his career at EY Switzerland in 2006 and worked as a Senior Manager in Audit and Financial Accounting Advisory Services until 2018. From 2018 to 2020, he was Head of Financial Reporting & Tax at Vifor Pharma Ltd. In 2021, he joined the Galenica Group as Head of Investor Relations & Corporate Finance.
• Qualification: German and French double degree of the European School of Business (Reutlingen/Reims), Swiss Certified Public Accountant, Advanced Management Program (IMD Lausanne).
• Other main activities: Mandates by order of Galenica: Member of the Board of MediService AG and Emeda AG. In addition, member of the Board of Trustees of the Galenica Pension Fund.

Andreas Koch
Chief Wholesale & Logistics

• Member of the Executive Committee of the Galenica Group since 2020, born 1971, German and Swiss citizen
• Career highlights: Between 2000 and 2009, Andreas Koch worked in different consulting and management functions in the field of supply chain management at various consulting firms. He then became Head of Supply Chain Management at Galexis – from 2011 also at Alloga – and was a member of both Executive Committees. In 2015, he rose to the position of Head of Alloga, after which he became Head of Galexis in 2019. In 2020, Andreas Koch took over the responsibility for the Services Business Sector at Galenica.
• Qualification: Apprenticeship as a forwarding & logistics manager, degree in business administration at the University of Mannheim and Programme for Executive Development (PED) at IMD Lausanne.
• Other main activities: Mandates by order of Galenica: Member of the Board of Directors of Health Supply AG, Pharmalog, Helvecura and GS1 Switzerland.

Daniele Madonna
Chief Pharmacies Category Management & Health Services

• Member of the Executive Committee of the Galenica Group since 2017, born in 1977, Swiss citizen
• Career highlights: After his studies, Daniele Madonna worked as a pharmacist at the Olympia Pharmacy and the Victoria Pharmacy in Zurich (2003 – 2004). He joined the former Galenica Group in 2004 as Manager of the Coop Vitality pharmacy in Tenero. He later acted as Regional Sales Manager at Coop Vitality (2010 – 2014). Daniele Madonna was CEO of Coop Vitality AG (2014 – 2018) before becoming Head Retail Business sector in 2017. Since 2021, he has served as Chief Healthcare Officer at Galenica.
• Qualification: He obtained the Federal Diploma in Pharmacy from the Federal Institute of Technology, Zurich (ETH), did further training as an FPH in Retail Pharmacy and a CAS in General Management at the University of St. Gallen (HSG) and completed the Programme for Executive Development (PED) at IMD in Lausanne.
• Other main activities: Member of the Board of pharmaSuisse. Mandates by order of Galenica: Member of the Board of Coop Vitality AG, Farmadomo Home Care Provider SA, Emeda AG and Apotheke im KSW AG.

Stephan Mignot
Chief Pharmacies Marketing

• Member of the Galenica Group Executive Committee since 1 September 2024, born 1976, Swiss citizen
• Career highlights: Stephan Mignot started his career at Swisscom Mobile in market analysis and marketing strategy and was later responsible for the M-Budget Mobile partnership with Swiss retailer Migros. From 2008 he was responsible for segment marketing at Swisscom and from 2013 for Customer Base Management in the Residential Customers segment. From 2020 to 2023, Stephan Mignot headed up Swisscom Residential Customer & Channel Management. He joined the Galenica Group in 2023 as Head of B2C Customer Marketing.
• Qualifications: Studied business administration at the University of Bern
• Master of Science (MSc) from the University of Bern, Certificate of Advanced Studies (CAS) in Agile Leadership from HWZ Zurich University of Applied Sciences in Business Administration
• Other main activities: -

Jürg Pauli
Chief Sustainability, Public Affairs & Transformation

• Member of the Extended Executive Committee of the Galenica Group since 2021, born in 1964, swiss citizen
• Career highlights: He started his career as a lawyer at the Swiss Bank Corporation (1993 – 1995) and as lawyer and member of the Executive Committee at a law firm (1995 – 1999). He worked in various roles, before he became first Head of Marketing Communications and then Head of Marketing at Swisscom Mobile (1999 – 2007). In 2008, he joined the Swisscom Group as Head of Pricing and Portfolio Design. Afterwards, he was appointed Head of Marketing Swisscom and member of the Executive Board for Swisscom (Switzerland) Ltd (2013 – 2016). In 2016, he became Head of Business Transformation at Swisscom. In 2020, he joined Galenica as Head of Transformation and Organisational Development and a member of the extended Executive Committee. Since 2024, he has served as Chief Sustainability, Public Affairs and Transformation.
• Qualifications: He studied law at the University of Berne and qualified as an advocate/attorney at law, Executive MBA at Bern-Rochester, training Transformation for Executives at IMD Lausanne and CAS in Agile Leadership.
• Other main activities: -

Barbara Wälchli
Group General Counsel and General Secretary

• Member of the Extended Executive Committee of the Galenica Group since 2021, born in 1981, Swiss citizen
• Career highlights: From 2011 to 2018, Barbara Wälchli worked as an attorney at law in various corporate law firms in Berne and Zurich. In 2018, she joined the Galenica Group as Senior Legal Counsel and, in the following year, became General Counsel. Since 2020, Barbara Wälchli has been the General Secretary and, since 2021, a member of the extended Executive Committee.
• Qualification: MLaw, LLM, attorney at law

Pascale Bruderer
Vice-Chairwoman of the Board of Directors

• Board member since 2020, born in 1977, Swiss citizen
• Corporate Governance: independent member
• Career highlights: Pascale Bruderer was a member of the National Council from 2002 to 2011 (president of the National Council 2009/2010) and a Member of the Council of States from 2011 to 2019. She was formerly a member of the Social Security and Health Committee. She served as president of the umbrella organisation for disabled people, Inclusion Handicap, and was the managing director of Krebsliga Aargau.
• Qualification: Master’s degree in political science from the University of Zurich and education at Harvard University in Boston (USA) and at the Executive School of the University of St. Gallen.
• Other main activities: Pascale Bruderer is a member of the Board of Directors of TX Group AG and Orell Füssli AG. Since 2019, she has been a member of the Board of Crossiety AG and since 2022, Chairwoman of the Board of Directors of Swiss Stablecoin AG. Elected by the Federal Council, she has served as Vice-President of the ETH Board since 2024.

Nadine Balkanyi-Nordmann

• Board member since 2025, born in 1972, Swiss citizen
• Corporate Governance: independent member
• Career highlights: Nadine Balkanyi-Nordmann is the founder and CEO of Lexperience AG. She has worked for prominent law firms and major financial institutions and has been educated at several international institutions. Following her time practicing law at Walder Wyss AG in Zurich, the Swiss attorney has held management positions for various banks such as UBS, GE Capital Bank and BNP Paribas in Switzerland, America and Asia
• Qualification: Nadine Balkanyi-Nordmann studied law at the University of Zurich and was admitted to the Zurich bar. She also holds an LL.M. (Master of Laws) from Hong Kong University. She has extensive knowledge on corporate governance and conducting administrative investigations in the public sector.
• Other main activities: Nadine Balkanyi-Nordmann has been a trustee at the Züsy + Daniel Guggenheim Stiftung since 2000 and Chair of the Board of Directors of Tele-Check Inter AG since 2017. She has also served as President of the Georg Wittlinger-Stiftung since 2021 and has been a member of the Board of Directors of Zoo Zurich AG since 2021.

Bertrand Jungo

• Board member since 2018, born in 1965, Swiss citizen
• Corporate Governance: independent member
• Career highlights: From 2006 to 2017, he held the position of CEO of the Swiss department store group Manor. From 2017 until 2020, he was CEO of Admeira AG, and from 2020 until 2021, he served as a member of the Board of Directors at Admeira AG. He was also a member of the Advisory Board of the International Retail Summit (IRS) of the Gottlieb Duttweiler Institute (GDI) (2010–2021).
• Qualification: Degree as business administrator lic.rer.pol from the University of Fribourg.
• Other main activities: Since 2021, he is the delegate of the Board of Directors of the AG Grand Hotels Engadinerkulm Holding St. Moritz. Furthermore, he is a member of the Board of Neoperl AG/Diaqua AG as well as at Zoologischer Garten Basel AG.

Prof. Dr med. Solange Peters

• Board member since 2023, born in 1972, Swiss citizen
• Corporate Governance: independent member
• Career highlights: Solange Peters is a professor at the University of Lausanne and head of the department of medical oncology at CHUV, the largest in Switzerland. She began working at CHUV in 2002, after a PhD in microbiology. Since 2006 she has worked in oncology. She is one of the world’s leading experts in the field of lung cancer and immunotherapy.
• Qualifications: Dr. medicine and biology, University of Lausanne.
• Other main activities: Solange Peters has been a member of ESMO (European Society for Medical Oncology) for over 10 years, and ESMO Chairwoman for the past three years. She is President of the ICF (International Cancer Foundation) since 2021 and President of the umbrella Swiss cancer organization Oncosuisse since 2024. She is a member of the board of the Swiss Cancer League since 2017 - and Vice-President since 2021, as well as chair of the Strategic Council of Paris Saclay Cancer Center (PSCC) since 2021.

Jörg Zulauf

• Board member since 2023, born in 1958, Swiss citizen
• Corporate Governance: independent member
• Career highlights: Jörg Zulauf spent 11 years in management positions at the Roche pharmaceutical Company in Switzerland, Korea and Germany, most recently as Head of the Vitamin Services World division (Finance & IT), which has operations worldwide. In 2000, Jörg Zulauf joined Migros-Genossenschafts-Bund Zürich, where he headed the Finance Department as Vice-Chairman of the Corporate Executive Committee until 2022 and was a member of the Retail, Finance and Audit committees. Jörg Zulauf has also served as a member of the Board of Directors of Hotelplan, Migrosbank and Globus, as well as Chairman of the Migros Pension Fund.
• Qualification: Master of Law and Attorney-at-Law, MBA (UCLA)
• Other main activities: Jörg Zulauf is a member of the Board of Directors at Maerki Baumann & Co Ltd and since 2023, he has been Chairman of the Board of Directors at SV Group AG. Furthermore, he is a member of the board of directors at Innflow AG, Rotkreuz.